• Nov. 7(Thu)
  • Nov. 8(Fri)

Nov. 7 (Thu)

Scientific Symposium 01

Current status of precision medicine in oncology area
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room A
Chair TBD
Speaker
  1. 1.Precision medicine in NSCLC: Current interpretation of biomarkers from NGS
    Myung-Ju AHN (Sungkyunkwan University School of Medicine, Korea)
  2. 2.Precision medicine in advanced prostate cancer
    Emmanuel S. ANTONARAKIS (Johns Hopkins University, USA)
  3. 3.Gastric cancer in the era of precision medicine
    Jeeyun LEE (Sungkyunkwan University School of Medicine, Korea)

Scientific Symposium 02

IT biotech & digital health in oncology
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room B
Chair TBD
Speaker
  1. 1.AI, big data and oncology
    Yoon Sup CHOI (DHP, Korea)
  2. 2.Artificial intelligence for lung cancer imaging
    Kyu-Hwan JUNG (Vuno, Korea)
  3. 3.AI technologies for diagnosis of rare genetic cancer
    Changwon KEUM (3 Billion, Korea)
  4. 4.Deep learning for cancer precision medicine
    Seong Eui HONG (Theragen, Korea)

Scientific Symposium 03

Immunotherapy: Emerging strategies for combination of immune checkpoint modulators
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room C
Chair TBD
Speaker
  1. 1.Immune-vascular crosstalk for improving cancer immunotherapy
    Chan KIM (CHA Bundang Medical Center, Korea)
  2. 2.Epigenetics interplay with cancer immunotherapy
    TBD
  3. 3.Co-inhibitory and co-stimulatory receptors combination in stimulating anti-tumor immunity
    TBD

Scientific Symposium 04

State of the art on systemic therapy in HCC
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room D
Chair TBD
Speaker
  1. 1.Targeted therapy and biomarkers in hepatocellular carcinoma
    Changhoon YOO (University of Ulsan College of Medicine, Korea)
  2. 2.Immunotherapy and biomarkers in hepatocellualar carcinoma
    Hong Jae CHON (CHA Bundang Medical Center, Korea)
  3. 3.Future of clinical trials in hepatocellular carcinoma
    Ann-Lii CHENG (National Taiwan University Hospital, Taiwan)

Plenary Lecture 01

Date & Time Nov. 7 (Thu), 10:30-11:10 Venue Room A
Chair TBD
Speaker Targeting DNA damage repair pathway *tentative
Andrew TUTT (The Institute of Cancer Research, UK)

Presidential Sympsoium

Date & Time Nov. 7 (Thu), 11:10-11:50 Venue Room A
Chair TBD
Speaker The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer
William G. KAELIN (Dana-Farber Cancer Institute, Harvard Medical School, USA)

Luncheon Symposium

Date & Time Nov. 7 (Thu),11:50-12:30 Venue TBD
Chair TBD
Speaker TBD

Special Symposium

Research, write, publish
Date & Time Nov. 7 (Thu), 12:50-13:50 Venue Room A
Chair TBD
Speaker
  1. 1.How to accept my manuscript to the high impact journal?
    Alex ADJEI (Mayo Clinic, USA)
  2. 2.Doing great research and writing great papers in high impact journals
    Jeong Ho LEE (KAIST, Korea)

Multidisciplinary Oncology Team Education Session 01 *KOR

Immuno-oncologic therapy and pharmacologic management
Date & Time Nov. 7 (Thu), 12:50-13:50 Venue Room C
Chair TBD
Speaker
  1. 1.Immune checkpoint inhibitors
    Jung Ae SEO (National Cancer Center, Korea)
  2. 2.Identification and management of toxicities with immuno-oncologic therapy
    Juhyang CHEON (Yeungnam University Hospital, Korea)
  3. 3.Oncology pharmacist’s role in immuno-oncologic therapy
    Soyeon HONG (Seoul National University Bundang Hospital, Korea)

ASCO/KSMO Joint Symposium

Progress in precision medicine through global collaboration
I. Utilization of NGS to improve patient care
Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room A
Chair TBD
Speaker
  1. 1.Precision genomics-based patients’ care - ASCO’s TAPUR study
    Edward KIM ( Levine Cancer Institute, Carolinas HealthCare System, USA)
  2. 2.Clinical applications of NGS in Korea
    Tae-You KIM (Seoul National University, Korea)
  3. 3.Global collaboration in genomic data sharing and use
    Subha MADHAVAN (Georgetown University, USA)

Scientific Symposium 05

Modulating microenvironment for cancer treatment
Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room B
Chair TBD
Speaker
  1. 1.Targeting microenvironment for cancer treatment
    TBD
  2. 2.Immune surveillance and the role of the endogenous angiogenesis inhibitors thrombospondin-1 and endostatin in tumor immunity
    Sandra RYEOM (UPENN, USA)
  3. 3.Leverages advanced technologies to investigate microbiomes and their clinical impact
    Julia OH (The Jackson Laboratory, USA)

KOSRO/KSMO Joint Symposium

The promise of combining RT and Immunotherapy
Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room C
Chair TBD
Speaker
  1. 1.Radiotherapy and Immunotherapy - New strategy for better outcome
    David RABEN (University of Colorado, USA)
  2. 2.Radiotherapy and Immunotherapy - On ongoing clinical trial
    Heerim Nam (Kangbuk Samsung Hospital, Korea)
  3. 3.Toxicities of the combination of radiotherapy and immunotherapy
    Keun-Wook LEE (Seoul National University Bundang Hospital, Korea)

Multidisciplinary Oncology Team Education Session 02 *KOR

Oncology nursing care in immune-oncology and targeted agent
Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room D
Chair TBD
Speaker
  1. 1.Principles of clinical advances of molecular targeted agent
    TBD
  2. 2.Principles of clinical advances of I-O
    Eun Joo KANG (Korea University, Korea)
  3. 3.Management of molecular targeted agent-related AEs
    Jae Ho JEONG (University of Ulsan College of Medicine, Korea)
  4. 4.Management of immune-related AEs
    Yun-Gyoo LEE (Kangbuk Samsung Hospital, Korea)

ASCO/KSMO Joint Symposium

Progress in precision medicine through global collaboration
II. Integrated platform for precision medicine
Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room A
Chair TBD
Speaker
  1. 1.Integrated precision medicine platform for data-sharing in USA
    TBD
  2. 2.How can we incorporate NGS data-sharing platform for precision medicine in Korea?
    Woong Yang PARK (Samsung Medical Center, Korea)
  3. 3.KSMO-KCSG Korean precision medicine networking group initiative
    Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)

Scientific Symposium 06

Translational Research - Biomarker studies to achieve desired clinical applications
Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room B
Chair TBD
Speaker
  1. 1.Development of CDK4/6 inhibitor for solid tumor
    Richard FINN (UCLA, USA)
  2. 2.Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma: insights for novel targeted therapies
    Qiang PAN-HAMMARSTRÖM (Karolinska Institutet, Sweden)
  3. 3.Integrative proteomics in prostate cancer
    TBD
  4. 4.Genomic predictors of clinical prognosis in gastric cancer
    Patrick TAN (NUS, Singapore)

Scientific Symposium 07

GY cancer multimodality treatment
Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room C
Chair TBD
Speaker
  1. 1.The role of PARPi in ovarian cancer
    Keun Ho LEE (The Catholic University of Korea, Korea)
  2. 2.IO for ovarian cancer  
    Gun Min KIM (Yonsei University College of Medicine, Korea)
  3. 3.Combination of PARP inhibitors and Immune checkpoint inhibitors in ovarian cancer 
    JJung-Min LEE (National Cancer Institute, USA)
  4. 4.International collaboration in GY cancer clinical research
    TBD

KCCA Symposium

The Current State and System of Overseas Drug Accessibility
Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room D
Chair TBD
Speaker
  1. TBD

Nov. 8 (Fri)

Scientific Symposium 08

Partnering between biotechs and investigators in early phase drug development
Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room A
Chair TBD
Speaker
  1. 1.How to navigate turbulent biotech as an investigator?
    James Jungkue LEE (Bridge Biotherapeutics, Inc., Korea)
  2. 2.PharmAbcine story and its Perspective in Oncology
    Jin-San YOO (PharmAbcine, Korea)
  3. 3.Looking inside from outside: MD perspective
    TBD
  4. 4.How to co-work between biotech and academia (ALT-P7 as a learning case): From biotech perspectives
    Soon Jae PARK (Alteogen, Korea)
  5. 5.How to co-work between biotech and academia (ALT-P7 as a learning case) : From academic perspectives
    Yeon Hee PARK (Sungkyunkwan University School of Medicine, Korea)

Scientific Symposium 09

Precision oncology and cancer epigenetics
Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room B
Chair TBD
Speaker
  1. 1.Understanding and targeting the epigenome in liver cancer
    Keith D. ROBERTSON (Mayo Clinic, USA)
  2. 2.Molecular mechanism underlying epigenetic carcinogenesis
    Young-Joon KIM (Yonsei University College of Medicine, Korea)
  3. 3.Treatment strategy targeting epigenetic mechanism in cancer
    Young-Hyeh KO (Samsung Medical Center, Korea)

KCSG/KSMO Joint Symposium

Multidisciplinary efforts for awareness and minimizing toxicities from systemic cancer therapy
Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room C
Chair TBD
Speaker
  1. 1.Endocrinopathy
    Tae Jung OH (Seoul National University Bundang Hospital, Korea)
  2. 2.Cardiovascular problems (CHF, arrhythmia etc)
    TBD
  3. 3.Pulmonology
    Eric LANCASTER (UPENN, USA)
  4. 4.Neurologic problems
    Jin-Hyoung KANG (The Catholic University of Korea, Korea)

Plenary Lecture 02

Date & Time Nov. 8 (Fri), 10:50-11:30 Venue Room A
Chair TBD
Speaker Past, present and future of geriatric oncology
Andrew TUTT (The Institute of Cancer Research, UK)

Noe Kyeong Kim Memorial Award & Lecture

Date & Time Nov. 8 (Fri), 11:30-12:10 Venue Room A
Chair TBD
Speaker TBD

Luncheon Symposium

Date & Time Nov. 8 (Fri), 12:10-12:50 Venue TBD
Chair TBD
Speaker TBD

Plenary Lecture 03

Date & Time Nov. 8 (Fri), 10:50-11:30 Venue Room A
Chair TBD
Speaker The reality versus potential of immune check-point inhibitors as cancer therapeutics
Heather WAKELEE (Stanford University , USA)

JSMO/KSMO Joint Symposium

Clinical Trials in Asia: Opportunities and Challenges
Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room A
Chair TBD
Speaker
  1. 1.How to make the biopharma companies to decide to conduct clinical trials in Asia?
    Takayuki YOSHINO (National Cancer Center Hospital East, Japan)
  2. 2.Early clinical research capabilities in Japan
    Toshio SHIMIZU (National Cancer Center Hospital, Japan)
  3. 3.Early clinical research capabilities in Korea
    Do-Youn OH (Seoul National University Hospital, Korea)
  4. 4.JSMO-KSMO collaboration for clinical trials
    Sun Young RHA (Yonsei University, Korea)

Scientific Symposium 10

Geriatric Oncology
Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room B
Chair TBD
Speaker
  1. 1.Geriatrics for oncologists
    Kwang Il KIM (Seoul National University, Korea)
  2. 2.Predicting outcome of older patients with cancer – Sharing Korean experiences
    Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)
  3. 3.How to improve cancer care for older patients - Sharing Singaporian experiences
    Ravindran KANESVARAN (National Cancer Centre Singapore, Singapore)
  4. 4.Breast cancer in older women
    Hans WILDIERS (University Hospitals Leuven, Belgium)

Scientific Symposium 11

Evolving strategies for surgery and systemic therapy in the neoadjuvant treatment era
Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room C
Chair TBD
Speaker
  1. 1.Neoadjuvant treatment for gastric cancer in Western countries
    TBD
  2. 2.Neoadjuvant treatment for gastric cancer in East Asian countries
    Masanori TERASHIMA ( Shizuoka Cancer Center, Japan)
  3. 3.Conversion surgery in metastatic gastric cancer
    Eun-Kee SONG (Chonbuk National University, Korea)

KSP/KSMO Joint Symposium

Immune Biomarker
Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room A
Chair TBD
Speaker
  1. 1.Present and future of IO biomarker
    TBD
  2. 2.PD-L1 in routine practice
    TBD
  3. 3.TMB: the role in IO prediction
    TBD
  4. 4.Multiplex immunoprofiling in cancer
    Hee Jin LEE (University of Ulsan College of Medicine, Korea)

Scientific Symposium 12

Radiomics: Primer for medical oncologists
Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room B
Chair TBD
Speaker
  1. 1.Radiomics and Deep learning in Differential Diagnosis and Molecular Classification
    Ji Eun Park (University of Ulsan College of Medicine, Korea)
  2. 2.Radiomics and Deep Learning in Monitoring Treatment Response
    Philipp Kickingereder (niversity Hospital Heidelberg, Germany)
  3. 3.Oncologist's view of radiomics
    Kyu Pyo Kim (University of Ulsan College of Medicine, Korea)
  4. 4.Radiomics in thoracic oncology
    Ho Yun LEE (Samsung Medical Center, Korea)

Oncology Multi-disciplinary Symposium

Multi-disciplinary Discussion on the Reimbursement Criteria of Imaging Studies in Cancer Patients
Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room C
Chair TBD
Speaker TBD

Multidisciplinary Oncology Team Education Session 03 *KOR

CRC/CRA in clinical trial of precision medicine
Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room D
Chair TBD
Speaker
  1. 1.Recent trend of clinical trials in a precision medicine era
    Jeong Eun KIM (University of Ulsan College of Medicine, Korea)
  2. 2.Real experience of a basket trial
    Jeong Eun KIM (University of Ulsan College of Medicine, Korea)
  3. 3.Real experience of a umbrella trial: TRIUMPH trail in H&N cancer, biomarker-integrated umbrella, advanced gastric cancer
    Hee Kyung AHN (Gachon University Gil Medical Center, Korea)